How Bryan Johnson’s efforts to ‘cure’ his autoimmune disease could reach patient forums, for better or worse

Bryan Johnson recently wrote on X: “Bad news #1: I have an autoimmune disease. My stomach is eating itself. Bad news #2: 2–5% of people have this, too. Likely more, because it hides. Good news: I'm going to try and solve it.”^[][] He’s trying to solve autoimmune gastritis (AIG).

For physicians, this raises a problem encountered more frequently during consultations now than ever before. When a patient influenced by the longevity culture meets a chronic autoimmune disease with no established curative therapy, how do you manage such a case?

That question is likely to surface well beyond the exam room, as patients trade test results, protocol ideas, and interpretations of Johnson’s experiment in online forums.

AIG can be managed, not cured

Ayesha Bryant, MD, MSPH, describes AIG as “an autoimmune disorder where the body destroys the parietal cells within the stomach that produce acid and intrinsic factor.” Over time, she says, this decreases stomach acid and intrinsic factor, impairing absorption of vitamin B12 and, commonly, iron. 

“Unlike many other gastrointestinal issues, there are very few ways that a patient with autoimmune gastritis can improve the condition through dietary modification, supplement use, or other lifestyle modifications,” Dr. Bryant says. “A healthy diet will promote overall wellness; however, it will not stop the immune destruction of parietal cells, nor replace those cells once they have been destroyed.” 

That is the part that longevity hacks can’t fix. A healthy diet is useful. Exercise is useful. Sleep is useful. But none of these replaces destroyed parietal cells. 

That may be a particularly difficult message in online spaces built around optimization, where disciplined lifestyle change is often presented as a solution to nearly every chronic condition.

Dr. Bryant says a clinician’s role in AIG shifts “from attempting to find a cure to identifying potential complications and preventing them when possible.” 

She says clinicians should watch for iron deficiency anemia, vitamin B12 deficiency anemia, peripheral neuropathy, and cognitive dysfunction. She also notes elevated risk for gastric neuroendocrine tumors and gastric adenocarcinoma. 

Iron deficiency deserves special attention

Dr. Bryant notes that “many patients exhibit chronic iron deficiency prior to developing overt vitamin B12 deficiency anemia,” making unexplained iron deficiency an important early indicator. 

That fits Johnson’s own account. He has said he had low ferritin for 11 years without anemia, despite attempts to raise iron through diet and supplementation. Johnson underwent colonoscopy, upper endoscopy, blood tests, and stomach biopsies, with elevated anti-parietal cell antibodies and biopsies confirming early autoimmune gastritis.^[]

Health tracking vs diagnosis

Alan Farrell, MD, chief medical officer at CHOOSEHealth, says additional testing “does not automatically improve our understanding of someone's health.”

In patient forums, those incidental abnormalities can acquire outsized meaning, particularly when they are interpreted alongside a high-profile biohacker’s account of a diagnosis that initially appeared as years of low ferritin.

Wearables and health tracking are not useless, though. Dr. Farrell says they help facilitate healthy behavior. But they are limited. A patient who relies on device data might misread normal biological variation as danger, or “overlook serious symptoms simply because the numbers appear unremarkable.” 

When a celebrity health experiment reaches patient forums

Johnson's language may be compelling in AIG and broader autoimmune-disease communities: A condition that "hides," a long history of unexplained low ferritin, and a public promise to "solve" it.

But forums can also turn one patient's highly resourced, individualized workup into a perceived playbook. Patients may begin comparing ferritin trends, ordering broad antibody or multiomic panels, or treating a normal wearable dashboard as reassurance that symptoms do not require clinical evaluation.